Lung cancer is a prevalent disease that, unfortunately, often goes unnoticed until its later stages. This is largely due to the subtlety of its early warning signs, which are frequently overlooked. The good news is that there are effective treatments available such as Opdivo (nivolumab), Zepzelca, Alecensa, Rybevrant, and ROS1 tyrosine kinase inhibitor (TKI) or ROS1 inhibitor. Let’s delve into the early warning signs of lung cancer that are often overlooked and the treatments available.

1. Persistent cough

A persistent cough that doesn’t go away or gets worse over time can be a sign of lung cancer. If you’ve had a cough for more than two weeks, it’s time to see a doctor.

2. Changes in cough

If your cough changes in sound or brings up blood or more mucus than usual, it could be a sign of lung cancer.

3. Breathing difficulties

Shortness of breath or becoming easily winded are also potential signs of lung cancer. These symptoms occur if lung cancer blocks or narrows an airway, or if fluid from a lung tumor builds up in the chest.

4. Chest pain

Lung cancer can cause pain in the chest, shoulder, or back. Whether the pain is constant or intermittent, it’s important to tell your doctor about it.

5. Hoarseness

If your voice becomes hoarse or if you’re constantly clearing your throat, it could be a sign of lung cancer. Hoarseness can be caused by a simple cold, but if it persists for more than two weeks, it’s worth getting checked out.

Once diagnosed, there are several treatments available. The choice of treatment depends on the type and stage of cancer, as well as the patient’s overall health.

Opdivo (nivolumab) is a type of immunotherapy that works by helping the immune system fight cancer cells. Zepzelca is used to treat small cell lung cancer that has spread to other parts of the body. Alecensa is an oral medication used to treat non-small cell lung cancer that has spread to other parts of the body or has come back. Rybevrant is a targeted therapy used for non-small cell lung cancer.

ROS1 tyrosine kinase inhibitor (TKI) or ROS1 inhibitor is used to treat patients with ROS1-positive non-small cell lung cancer. These inhibitors work by blocking the activity of the ROS1 protein, which helps stop the growth and spread of cancer cells.

In conclusion, early detection of lung cancer is crucial for effective treatment. Paying attention to the warning signs and seeking medical advice when they appear can significantly improve the prognosis. With advancements in medical treatments like Opdivo (nivolumab), Zepzelca, Alecensa, Rybevrant, and ROS1 inhibitors, there’s hope for those diagnosed with this disease.